Centre for Advancing Health Outcomes, Vancouver, British Columbia, Canada.
School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
J Int AIDS Soc. 2024 Jul;27 Suppl 1(Suppl 1):e26265. doi: 10.1002/jia2.26265.
INTRODUCTION: Improving the delivery of existing evidence-based interventions to prevent and diagnose HIV is key to Ending the HIV Epidemic in the United States. Structural barriers in the access and delivery of related health services require municipal or state-level policy changes; however, suboptimal implementation can be addressed directly through interventions designed to improve the reach, effectiveness, adoption or maintenance of available interventions. Our objective was to estimate the cost-effectiveness and potential epidemiological impact of six real-world implementation interventions designed to address these barriers and increase the scale of delivery of interventions for HIV testing and pre-exposure prophylaxis (PrEP) in three US metropolitan areas. METHODS: We used a dynamic HIV transmission model calibrated to replicate HIV microepidemics in Atlanta, Los Angeles (LA) and Miami. We identified six implementation interventions designed to improve HIV testing uptake ("Academic detailing for HIV testing," "CyBER/testing," "All About Me") and PrEP uptake/persistence ("Project SLIP," "PrEPmate," "PrEP patient navigation"). Our comparator scenario reflected a scale-up of interventions with no additional efforts to mitigate implementation and structural barriers. We accounted for potential heterogeneity in population-level effectiveness across jurisdictions. We sustained implementation interventions over a 10-year period and evaluated HIV acquisitions averted, costs, quality-adjusted life years and incremental cost-effectiveness ratios over a 20-year time horizon (2023-2042). RESULTS: Across jurisdictions, implementation interventions to improve the scale of HIV testing were most cost-effective in Atlanta and LA (CyBER/testing cost-saving and All About Me cost-effective), while interventions for PrEP were most cost-effective in Miami (two of three were cost-saving). We estimated that the most impactful HIV testing intervention, CyBER/testing, was projected to avert 111 (95% credible interval: 110-111), 230 (228-233) and 101 (101-103) acquisitions over 20 years in Atlanta, LA and Miami, respectively. The most impactful implementation intervention to improve PrEP engagement, PrEPmate, averted an estimated 936 (929-943), 860 (853-867) and 2152 (2127-2178) acquisitions over 20 years, in Atlanta, LA and Miami, respectively. CONCLUSIONS: Our results highlight the potential impact of interventions to enhance the implementation of existing evidence-based interventions for the prevention and diagnosis of HIV.
简介:改善现有循证干预措施的提供以预防和诊断 HIV 是在美国终结 HIV 流行的关键。获取和提供相关卫生服务方面的结构性障碍需要市级或州级政策的改变;然而,通过旨在提高现有干预措施的可及性、有效性、采用或维持的干预措施,可直接解决实施方面的不足。我们的目标是评估六项旨在解决这些障碍并扩大 HIV 检测和暴露前预防(PrEP)干预措施提供规模的真实世界实施干预措施的成本效益和潜在的流行病学影响,这六项干预措施分别设计用于提高 HIV 检测的采用率(“艾滋病毒检测学术详述”、“CyBER/testing”、“All About Me”)和 PrEP 的采用率/维持率(“Project SLIP”、“PrEPmate”、“PrEP 患者导航”)。
方法:我们使用了一种经过校准的动态 HIV 传播模型,以复制亚特兰大、洛杉矶(LA)和迈阿密的 HIV 微观流行。我们确定了六项旨在提高 HIV 检测率(“艾滋病毒检测学术详述”、“CyBER/testing”、“All About Me”)和 PrEP 采用/维持率(“Project SLIP”、“PrEPmate”、“PrEP 患者导航”)的实施干预措施。我们的对照方案反映了在没有额外努力减轻实施和结构性障碍的情况下扩大干预措施的规模。我们考虑了不同司法管辖区内人群层面效果的潜在异质性。我们在 10 年内维持实施干预措施,并在 20 年的时间内评估了(2023-2042 年)避免的艾滋病毒感染、成本、质量调整生命年和增量成本效益比。
结果:在所有司法管辖区内,改善 HIV 检测规模的实施干预措施在亚特兰大和洛杉矶(CyBER/testing 节省成本,All About Me 具有成本效益)最具成本效益,而 PrEP 的干预措施在迈阿密最具成本效益(三种中有两种节省成本)。我们估计,最具影响力的 HIV 检测干预措施 CyBER/testing 预计将在 20 年内分别在亚特兰大、洛杉矶和迈阿密避免 111(95%可信区间:110-111)、230(228-233)和 101(101-103)例感染。提高 PrEP 参与度的最具影响力的实施干预措施 PrEPmate,预计将在 20 年内分别在亚特兰大、洛杉矶和迈阿密避免 936(929-943)、860(853-867)和 2152(2127-2178)例感染。
结论:我们的研究结果突出了加强现有预防和诊断 HIV 的循证干预措施实施的干预措施的潜在影响。
Cochrane Database Syst Rev. 2008-7-16
BMC Health Serv Res. 2025-7-1
J Int AIDS Soc. 2024-7
Health Aff (Millwood). 2023-4
Front Health Serv. 2022-2-4
J Acquir Immune Defic Syndr. 2023-6-1
J Am Coll Clin Pharm. 2022-9